Novavax Aktie
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 9 | 1 | 0 | 163,14 GBP | - |
| Bayer | 7 | 2 | 0 | 59,19 EUR | +9,65% |
| BioNTech (ADRs) | 5 | 2 | 0 | 122,71 USD | +51,57% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 0 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 1 | 4 | 4 | 35,17 EUR | -6,56% |
| Fresenius SE & Co. KGaA | 7 | 1 | 0 | 56,89 EUR | +10,94% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Inovio Pharmaceuticals Inc | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 1 | 0 | 45,00 USD | -76,92% |
| Novartis AG | 1 | 7 | 2 | 123,90 CHF | -3,02% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 1 | 6 | 1 | 28,43 USD | +3,76% |
| Roche Holding AG Inhaber-Partizipationsschein | 4 | 4 | 1 | 383,44 CHF | -3,37% |
| Sanofi S.A. | 5 | 5 | 0 | 94,11 EUR | +8,21% |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |